Literature DB >> 9069501

MRI demonstration of reversible impairment of the blood-CNS barrier function in subacute combined degeneration of the spinal cord.

W Küker, V Hesselmann, A Thron, A de Simone.   

Abstract

Mesh:

Year:  1997        PMID: 9069501      PMCID: PMC1064175          DOI: 10.1136/jnnp.62.3.298

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Magnetic resonance imaging in cobalamin deficiency.

Authors:  J P Tracey; F J Schiffman
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

2.  Reversible myelopathy with pernicious anemia: clinical/MR correlation.

Authors:  J R Berger; R Quencer
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

3.  Subacute combined degeneration of the spinal cord: MRI detection of preferential involvement of the posterior columns in a child.

Authors:  L J Wolansky; G Goldstein; A Gozo; H J Lee; I Sills; S Chatkupt
Journal:  Pediatr Radiol       Date:  1995

4.  MRI in subacute combined degeneration.

Authors:  S Murata; H Naritomi; T Sawada
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

  4 in total
  3 in total

Review 1.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

2.  Imaging features of copper deficiency myelopathy: a study of 25 cases.

Authors:  Neeraj Kumar; J Eric Ahlskog; Christopher J Klein; John D Port
Journal:  Neuroradiology       Date:  2005-10-28       Impact factor: 2.804

3.  Early treatment causes clinicoradiological reversal of myelopathy due to vitamin B12 deficiency.

Authors:  Rajesh Verma; Prakash Kori; Tushar B Patil; Heramba Narayan Praharaj
Journal:  BMJ Case Rep       Date:  2013-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.